Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact-Reference-Cited by-同舟云学术

Dual angiotensin receptor and neprilysin inhibition as an alternative to angiotensin-converting enzyme inhibition in patients with chronic systolic heart failure: rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact

Published:2013-09 Issue:9 Volume:15 Page:1062-1073
ISSN:1388-9842
Container-title:European Journal of Heart Failure
language:en
Short-container-title:European Journal of Heart Failure

Author:

McMurray John J. V.¹,Packer Milton²,Desai Akshay S.³,Gong Jim⁴,Lefkowitz Martin P.⁴,Rizkala Adel R.⁴,Rouleau Jean⁵,Shi Victor C.⁴,Solomon Scott D.³,Swedberg Karl⁶,Zile Michael R.⁷,

Affiliation:

1. BHF Cardiovascular Research Centre; University of Glasgow; Glasgow UK

2. University of Texas Southwestern Medical Center; Dallas TX USA

3. Brigham and Women's Hospital; Cardiovascular Medicine; MA USA

4. Novartis Pharmaceutical Corporation; East Hanover NJ USA

5. Université de Montréal; Institut de Cardiologie; Montréal Canada

6. University of Gothenburg; Cardiovascular Medicine Department; Gothenburg Sweden

7. The Medical University of South Carolina and RHJ Department of Veterans Administration Medical center; Charleston SC USA

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine